Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thrombotic Microangiopathies | 9 | 2024 | 53 | 3.560 |
Why?
|
| Complement Pathway, Alternative | 6 | 2019 | 14 | 2.070 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 6 | 2024 | 1187 | 1.830 |
Why?
|
| Pulmonary Embolism | 4 | 2024 | 189 | 1.630 |
Why?
|
| Thrombosis | 9 | 2024 | 547 | 1.420 |
Why?
|
| Venous Thromboembolism | 4 | 2025 | 185 | 1.260 |
Why?
|
| Anticoagulants | 7 | 2025 | 615 | 1.050 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 4 | 2022 | 57 | 1.050 |
Why?
|
| Kidney Glomerulus | 2 | 2018 | 84 | 1.040 |
Why?
|
| Endothelial Cells | 4 | 2018 | 544 | 0.930 |
Why?
|
| Hemorrhage | 3 | 2025 | 514 | 0.820 |
Why?
|
| Plasma Exchange | 2 | 2024 | 89 | 0.760 |
Why?
|
| Warfarin | 1 | 2023 | 125 | 0.760 |
Why?
|
| Complement Activation | 2 | 2019 | 53 | 0.730 |
Why?
|
| Anemia, Sickle Cell | 1 | 2024 | 346 | 0.660 |
Why?
|
| Complement C3b | 1 | 2019 | 7 | 0.650 |
Why?
|
| Complement Factor B | 1 | 2019 | 11 | 0.650 |
Why?
|
| Patient Care Team | 1 | 2024 | 574 | 0.630 |
Why?
|
| Microvessels | 2 | 2020 | 63 | 0.600 |
Why?
|
| Child | 23 | 2025 | 25890 | 0.580 |
Why?
|
| Protein C | 1 | 2015 | 21 | 0.500 |
Why?
|
| Endothelium, Vascular | 2 | 2020 | 522 | 0.490 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 549 | 0.470 |
Why?
|
| Biomarkers | 3 | 2024 | 3434 | 0.470 |
Why?
|
| Thrombolytic Therapy | 4 | 2025 | 213 | 0.450 |
Why?
|
| von Willebrand Factor | 4 | 2023 | 205 | 0.370 |
Why?
|
| Vena Cava, Inferior | 2 | 2021 | 103 | 0.340 |
Why?
|
| Humans | 34 | 2025 | 134156 | 0.330 |
Why?
|
| Venous Thrombosis | 2 | 2022 | 173 | 0.320 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 807 | 0.320 |
Why?
|
| Hemolytic-Uremic Syndrome | 2 | 2022 | 36 | 0.310 |
Why?
|
| Alligators and Crocodiles | 1 | 2008 | 1 | 0.310 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2021 | 121 | 0.300 |
Why?
|
| Amputation, Traumatic | 1 | 2008 | 11 | 0.300 |
Why?
|
| Arm Injuries | 1 | 2008 | 15 | 0.300 |
Why?
|
| Bites and Stings | 1 | 2008 | 27 | 0.300 |
Why?
|
| Atypical Hemolytic Uremic Syndrome | 3 | 2018 | 9 | 0.300 |
Why?
|
| Adolescent | 11 | 2024 | 20624 | 0.290 |
Why?
|
| Debridement | 1 | 2008 | 91 | 0.290 |
Why?
|
| Retrospective Studies | 10 | 2024 | 17540 | 0.280 |
Why?
|
| Brain | 1 | 2018 | 3224 | 0.240 |
Why?
|
| Coronavirus Infections | 2 | 2022 | 385 | 0.240 |
Why?
|
| Pneumonia, Viral | 2 | 2022 | 396 | 0.240 |
Why?
|
| Child, Preschool | 7 | 2024 | 14884 | 0.240 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2018 | 703 | 0.220 |
Why?
|
| Infant | 7 | 2024 | 13240 | 0.210 |
Why?
|
| International Normalized Ratio | 1 | 2023 | 44 | 0.210 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2022 | 198 | 0.200 |
Why?
|
| Adult | 8 | 2024 | 31945 | 0.190 |
Why?
|
| Health Information Systems | 1 | 2022 | 35 | 0.190 |
Why?
|
| Blood Coagulation Disorders | 1 | 2023 | 110 | 0.190 |
Why?
|
| Thromboembolism | 1 | 2022 | 92 | 0.190 |
Why?
|
| Aortic Diseases | 2 | 2024 | 203 | 0.180 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 322 | 0.170 |
Why?
|
| Lung Diseases | 1 | 2024 | 404 | 0.170 |
Why?
|
| Lower Extremity | 1 | 2021 | 188 | 0.150 |
Why?
|
| Male | 11 | 2024 | 66127 | 0.150 |
Why?
|
| Immunoassay | 2 | 2015 | 139 | 0.150 |
Why?
|
| Complement Factor H | 2 | 2015 | 24 | 0.150 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2018 | 14 | 0.150 |
Why?
|
| Complement C3a | 1 | 2018 | 19 | 0.150 |
Why?
|
| Complement C5a | 1 | 2018 | 25 | 0.140 |
Why?
|
| Receptors, Complement | 1 | 2018 | 33 | 0.140 |
Why?
|
| Inpatients | 1 | 2022 | 547 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 2 | 2015 | 337 | 0.140 |
Why?
|
| Fibrinolytic Agents | 1 | 2019 | 208 | 0.130 |
Why?
|
| Pediatric Obesity | 1 | 2022 | 410 | 0.130 |
Why?
|
| Young Adult | 5 | 2024 | 9944 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 2578 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 306 | 0.130 |
Why?
|
| Female | 9 | 2024 | 71928 | 0.120 |
Why?
|
| Cohort Studies | 2 | 2023 | 5222 | 0.120 |
Why?
|
| RNA, Messenger | 1 | 2022 | 2915 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1506 | 0.120 |
Why?
|
| Hospitalization | 1 | 2024 | 1906 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 434 | 0.120 |
Why?
|
| Muscle Proteins | 1 | 2018 | 425 | 0.120 |
Why?
|
| Platelet Activation | 1 | 2015 | 71 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 704 | 0.110 |
Why?
|
| Platelet Aggregation | 1 | 2015 | 125 | 0.110 |
Why?
|
| Anemia, Aplastic | 1 | 2015 | 62 | 0.110 |
Why?
|
| Risk Factors | 3 | 2024 | 11182 | 0.110 |
Why?
|
| Fibrinogen | 1 | 2015 | 163 | 0.110 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 544 | 0.110 |
Why?
|
| Cytoplasm | 1 | 2015 | 304 | 0.110 |
Why?
|
| Prognosis | 2 | 2023 | 5086 | 0.110 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2015 | 128 | 0.110 |
Why?
|
| Antigens, CD | 1 | 2015 | 451 | 0.110 |
Why?
|
| Hemostasis | 2 | 2025 | 72 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 548 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2015 | 837 | 0.100 |
Why?
|
| Gene Expression | 1 | 2018 | 1621 | 0.100 |
Why?
|
| Bone Marrow | 1 | 2015 | 336 | 0.100 |
Why?
|
| Models, Biological | 1 | 2018 | 1539 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3668 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2018 | 3188 | 0.090 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 703 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5477 | 0.080 |
Why?
|
| Inflammation | 1 | 2018 | 1595 | 0.080 |
Why?
|
| Infant, Newborn | 4 | 2024 | 8623 | 0.080 |
Why?
|
| Consensus | 2 | 2023 | 732 | 0.080 |
Why?
|
| Transcriptome | 1 | 2015 | 1138 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2008 | 188 | 0.070 |
Why?
|
| Hematology | 1 | 2025 | 43 | 0.060 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2023 | 39 | 0.050 |
Why?
|
| Thrombectomy | 1 | 2024 | 107 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2023 | 41 | 0.050 |
Why?
|
| Pandemics | 2 | 2022 | 1190 | 0.050 |
Why?
|
| Complement System Proteins | 1 | 2023 | 61 | 0.050 |
Why?
|
| ADAMTS13 Protein | 1 | 2022 | 67 | 0.050 |
Why?
|
| ADAM Proteins | 1 | 2022 | 87 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2025 | 13074 | 0.050 |
Why?
|
| Germ Cells | 1 | 2023 | 204 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 1979 | 0.040 |
Why?
|
| Potassium | 1 | 2022 | 290 | 0.040 |
Why?
|
| Immunization | 1 | 2022 | 315 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 309 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2025 | 778 | 0.040 |
Why?
|
| Data Collection | 1 | 2022 | 399 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2023 | 370 | 0.040 |
Why?
|
| Biopsy | 1 | 2024 | 1304 | 0.040 |
Why?
|
| Microcirculation | 1 | 2020 | 117 | 0.040 |
Why?
|
| Graft vs Host Disease | 1 | 2024 | 619 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 190 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2022 | 574 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2025 | 1340 | 0.040 |
Why?
|
| Communication | 1 | 2022 | 542 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2022 | 873 | 0.040 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 214 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2022 | 791 | 0.030 |
Why?
|
| Lung | 1 | 2024 | 1577 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 1317 | 0.030 |
Why?
|
| Weibel-Palade Bodies | 1 | 2015 | 1 | 0.030 |
Why?
|
| Models, Immunological | 1 | 2015 | 38 | 0.030 |
Why?
|
| Complement C3 | 1 | 2015 | 54 | 0.030 |
Why?
|
| Clonal Evolution | 1 | 2015 | 49 | 0.030 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2014 | 7 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2015 | 109 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2998 | 0.030 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2014 | 25 | 0.030 |
Why?
|
| Medical Records | 1 | 2015 | 194 | 0.030 |
Why?
|
| Animals | 2 | 2020 | 36557 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1132 | 0.030 |
Why?
|
| Time Factors | 1 | 2022 | 6610 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2015 | 1599 | 0.020 |
Why?
|
| United States | 1 | 2025 | 11763 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2301 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3857 | 0.020 |
Why?
|